SBE-β-CD
Detailed Description
SBE-β-CDSBE-β-CD (Sulfobutylether-β-Cyclodextrin; Captisol) is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs; Captisol is the trademark of SBE-β-CD registered by Ligand Pharmaceuticals.
IC50 value:
Target: Drug adjuvant
SBE-β-CD is a unique reproducible mixture of polyanionic β-cyclodextrin derivatives in which a sodium sulfonate salt is tethered to the lipophilic cyclodextrin cavity by a butyl ether group, or sulfobutylether (SBE).
Target:Others
Product Links:http://www.medchemexpress.cn/captisol.html
Permanent link:http://www.medchemexpress.com/SBE-_beta_-CD.html